Related Experiment Videos
Hepatitis C: epidemiology and review of complementary/alternative medicine treatments
Insights
Hepatitis C is a growing global health issue. This review examines botanical compounds and antioxidants for treating liver damage and chronic hepatitis C.
Area of Science:
- Hepatology
- Virology
- Immunology
- Natural Products Chemistry
Background:
- Hepatitis C is a significant worldwide health concern with potentially devastating long-term consequences.
- The disease has a long latency period, often leading to diagnosis only when advanced liver damage like cirrhosis is present.
- Hepatic damage results from both the direct viral effects and the body's immune response.
Purpose of the Study:
- To review the efficacy of specific botanical components and antioxidants in managing chronic hepatitis C.
- To assess the potential of these natural compounds in mitigating liver damage associated with Hepatitis C infection.
Main Methods:
- Literature review of studies investigating botanical compounds (glycyrrhizin, catechin, silymarin, phytosterols) and antioxidants (N-acetylcysteine, vitamin E).
- Analysis of research on their impact on chronic hepatitis and liver damage markers.
- Evaluation of diagnostic methods, including liver biopsy, for staging Hepatitis C.
Main Results:
- Hepatitis C can lead to severe liver conditions including fibrosis, cirrhosis, and hepatocellular carcinoma.
- Extrapatic manifestations include lichen planus, glomerulonephritis, mixed cryoglobulinemia, and porphyria.
- The review synthesizes evidence on the therapeutic potential of selected natural compounds and antioxidants.
Conclusions:
- Early diagnosis and assessment of Hepatitis C are crucial for effective treatment planning.
- Botanical components and antioxidants show promise in managing chronic hepatitis and reducing liver damage.
- Further research is warranted to fully elucidate the mechanisms and clinical applications of these agents.
Abstract:
Hepatitis C is emerging as a serious worldwide problem. In the United States the current mortality figures may triple in the next ten years, rivaling HIV. The disease has a latency of 10-30 years and symptoms or signs may not appear until cirrhosis is evident. Adequate diagnosis, including liver biopsy, is essential in assessing the current stage of the viral infection and the need for treatment. Hepatitis C may manifest as hepatic fibrosis, cirrhosis, hepatocellular carcinoma, lichen planus, glomerulonephritis, mixed cryoglobulinemia, or porphyria. The hepatic damage is due both to the cytopathic effect of the virus and the inflammatory changes secondary to immune activation. The use of the botanical components glycyrrhizin, catechin, silymarin and phytosterols, and the antioxidants N-acetylcysteine and vitamin E are reviewed for their efficacy in treating chronic hepatitis and affecting liver damage.